Invention Grant
- Patent Title: Anti-EMR1 antibodies
- Patent Title (中): 抗EMR1抗体
-
Application No.: US13480937Application Date: 2012-05-25
-
Publication No.: US09045539B2Publication Date: 2015-06-02
- Inventor: Kenneth Luehrsen , Mark Baer , Christopher R. Bebbington , David Martinez , Varghese Palath , Swathi Sujatha-Bhaskar , Nenad Tomasevic , Jason Williams , Geoffrey T. Yarranton
- Applicant: Kenneth Luehrsen , Mark Baer , Christopher R. Bebbington , David Martinez , Varghese Palath , Swathi Sujatha-Bhaskar , Nenad Tomasevic , Jason Williams , Geoffrey T. Yarranton
- Applicant Address: US CA South San Francisco
- Assignee: Kalobios Pharmaceuticals, Inc.
- Current Assignee: Kalobios Pharmaceuticals, Inc.
- Current Assignee Address: US CA South San Francisco
- Agency: Kilpatrick Townsend & Stockton LLP
- Main IPC: A61K39/395
- IPC: A61K39/395 ; G01N33/566 ; C07K16/28 ; A61K39/00
Abstract:
The invention provides anti-EGF-like module containing, mucin-like, hormone receptor-like 1 (EMR1) antibodies and methods of using such antibodies to treat EMR1-related diseases.
Public/Granted literature
- US20130064826A1 ANTI-EMR1 ANTIBODIES Public/Granted day:2013-03-14
Information query
